| AB SICAV I-EMERGING MARKETS OPPORTUNITIES PORTFOLIO I EUR | RVI EMERGENTES | 43,15% | · | · | · |
| BARINGS EASTERN EUROPE FUND I USD ACC | RVI EMERGENTES EUROPA | 43,15% | 132,35% | · | · |
| MFS INVESTMENT FUNDS - BLENDED RESEARCH EMERGING MARKETS EQUITY FUND US DOLLAR CAP | RVI EMERGENTES | 43,15% | 102,39% | 88,13% | · |
| ROBECO SMART ENERGY X CHF | RVI ENERGÍA | 43,15% | 91,00% | · | · |
| T.ROWE GLOBAL TECHNOLOGY EQUITY FUND AH (EUR) | RVI TECNOLOGÍA | 43,14% | 160,17% | 33,25% | · |
| WELLINGTON EMERGING MARKETS RESEARCH EQUITY N USD ACC | RVI EMERGENTES | 43,14% | 89,26% | 51,99% | · |
| UBS CMCI EX-AGRICULTURE SF UCITS ETF USD ACC | RVI MATERIAS PRIMAS | 43,13% | · | · | · |
| ROBECO SMART ENERGY F EUR | RVI ENERGÍA | 43,12% | 90,37% | 84,59% | · |
| T.ROWE EMERGING MARKETS EQUITY FUND I10 | RVI EMERGENTES | 43,12% | 61,64% | 25,48% | 90,73% |
| BNP PARIBAS ASIA EX-JAPAN EQUITY CLASSIC USD CAP | RVI ASIA EX-JAPÓN | 43,11% | 86,69% | 48,03% | 103,34% |
| AB FCP II-EMERGING MARKETS VALUE PORTFOLIO A EUR | RVI EMERGENTES VALOR | 43,10% | 77,01% | 70,34% | 114,86% |
| PICTET - BIOTECH P DY USD | RVI BIOTECNOLOGÍA | 43,10% | 77,61% | 49,80% | 125,69% |
| PICTET - BIOTECH P USD | RVI BIOTECNOLOGÍA | 43,10% | 77,61% | 49,80% | 125,67% |
| CAIXABANK MASTER RENTA VARIABLE EMERGENTE ADVISED BY, FI | RVI EMERGENTES | 43,08% | 92,69% | 65,40% | · |
| T.ROWE EMERGING MARKETS EQUITY FUND I | RVI EMERGENTES | 43,08% | 61,42% | 24,94% | 85,96% |
| T.ROWE EMERGING MARKETS EQUITY FUND I (EUR) | RVI EMERGENTES | 43,07% | 61,32% | 24,89% | 85,54% |
| AB FCP I-EMERGING MARKETS GROWTH PORTFOLIO S1 GBP | RVI EMERGENTES CRECIMIENTO | 43,05% | 84,21% | 52,41% | 114,47% |
| BARINGS EASTERN EUROPE FUND I EUR ACC | RVI EMERGENTES EUROPA | 43,05% | 132,43% | · | · |
| MFS MERIDIAN EMERGING MARKETS EQUITY RESEARCH FUND WH1-GBP | RVI EMERGENTES | 43,03% | 93,50% | 52,00% | · |
| BGF NEXT GENERATION TECHNOLOGY S2 CHF (HEDGED) | RVI TECNOLOGÍA | 43,01% | 132,67% | 33,61% | · |
